Cargando…

Genetic clinicians' confidence in BOADICEA comprehensive breast cancer risk estimates and counselees' psychosocial outcomes: A prospective study

Counseling for familial breast cancer focuses on communicating the gene test result (GENE) to counselees, but risk prediction models have become more complex by including non‐genetic risk factors (NGRF) and polygenic risk scores (PRS). We examined genetic clinicians' confidence in counseling an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brédart, Anne, De Pauw, Antoine, Tüchler, Anja, Lakeman, Inge M. M., Anota, Amélie, Rhiem, Kerstin, Schmutzler, Rita, van Asperen, Christi J., Devilee, Peter, Stoppa‐Lyonnet, Dominique, Kop, Jean‐Luc, Dolbeault, Sylvie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322298/ https://www.ncbi.nlm.nih.gov/pubmed/35508697 http://dx.doi.org/10.1111/cge.14147

Ejemplares similares

Assessment of psychosocial difficulties by genetic clinicians and distress in women at high risk of breast cancer: a prospective study
por: Brédart, Anne, et al.
Publicado: (2022)

Use of the BOADICEA Web Application in clinical practice: appraisals by clinicians from various countries
por: Brédart, Anne, et al.
Publicado: (2017)

Information needs on breast cancer genetic and non-genetic risk factors in relatives of women with a BRCA1/2 or PALB2 pathogenic variant
por: Brédart, Anne, et al.
Publicado: (2021)

Psychosocial problems in women attending French, German and Spanish genetics clinics before and after targeted or multigene testing results: an observational prospective study
por: Brédart, Anne, et al.
Publicado: (2019)

Patient-Centered Care in Breast Cancer Genetic Clinics
por: Brédart, Anne, et al.
Publicado: (2018)

Clinicians’ use of breast cancer risk assessment tools according to their perceived importance of breast cancer risk factors: an international survey
por: Brédart, Anne, et al.
Publicado: (2018)

Short-term psychological impact of the BRCA1/2 test result in women with breast cancer according to their perceived probability of genetic predisposition to cancer
por: Brédart, A, et al.
Publicado: (2013)

Psychological factors and the uptake of preventative measures in BRCA1/2 pathogenic variant carriers: results of a prospective cohort study
por: Dick, Julia, et al.
Publicado: (2022)

Remarks on the BOADICEA model of genetic susceptibility to breast and ovarian cancer
por: van Asperen, C J, et al.
Publicado: (2005)

Validation of the BOADICEA model and a 313-variant polygenic risk score for breast cancer risk prediction in a Dutch prospective cohort
por: Lakeman, Inge M. M., et al.
Publicado: (2020)

Communication in cancer genetic counselling: does it reflect counselees' previsit needs and preferences?
por: Pieterse, A H, et al.
Publicado: (2005)

Design and Feasibility of an Intervention to Support Cancer Genetic Counselees in Informing their At-Risk Relatives
por: de Geus, Eveline, et al.
Publicado: (2016)

The BOADICEA model of genetic susceptibility to breast and ovarian cancer
por: Antoniou, A C, et al.
Publicado: (2004)

Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model
por: Mavaddat, Nasim, et al.
Publicado: (2023)

Cancer Genetic Counseling: Communication and Counselees’ Post-Visit Satisfaction, Cognitions, Anxiety, and Needs Fulfillment
por: Pieterse, Arwen H., et al.
Publicado: (2007)

The use of telephone in genetic counseling versus in-person counseling: a randomized study on counselees’ outcome
por: Platten, Ulla, et al.
Publicado: (2012)

Uncertainty related to multigene panel testing for cancer: a qualitative study on counsellors’ and counselees’ views
por: Medendorp, Niki M., et al.
Publicado: (2018)

Counselees’ Expressed Level of Understanding of the Risk Estimate and Surveillance Recommendation are Not Associated with Breast Cancer Surveillance Adherence
por: Albada, Akke, et al.
Publicado: (2016)

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
por: Antoniou, A C, et al.
Publicado: (2008)

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
por: Antoniou, A C, et al.
Publicado: (2008)

Clinical software development for the Web: lessons learned from the BOADICEA project
por: Cunningham, Alex P, et al.
Publicado: (2012)

Palliative care in day-hospital for advanced cancer patients: a study protocol for a multicentre randomized controlled trial
por: Thery, Laura, et al.
Publicado: (2021)

Hormone Replacement Therapy after Prophylactic Adnexectomy
por: This, Pascale, et al.
Publicado: (2005)

Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C, RAD51D, BARD1 updates to tumour pathology and cancer incidence
por: Lee, Andrew, et al.
Publicado: (2022)

What Causes Cancer in Women with a gBRCA Pathogenic Variant? Counselees’ Causal Attributions and Associations with Perceived Control
por: Kendel, Friederike, et al.
Publicado: (2022)

A longitudinal analysis of patient satisfaction with care and quality of life in ambulatory oncology based on the OUT-PATSAT35 questionnaire
por: Nguyen, Thanh Vân France, et al.
Publicado: (2014)

Reply: Remarks on the BOADICEA model of genetic susceptibility to breast and ovarian Cancer Research UK
por: Antoniou, A C, et al.
Publicado: (2005)

Evaluation of the BOADICEA risk assessment model in women with a family history of breast cancer
por: Ståhlbom, Anne Kinhult, et al.
Publicado: (2011)

Streamlining Decision Making in Contralateral Risk-Reducing Mastectomy: Impact of PREDICT and BOADICEA Computations
por: de Silva, Tania Samantha, et al.
Publicado: (2018)

Machine learning techniques for personalized breast cancer risk prediction: comparison with the BCRAT and BOADICEA models
por: Ming, Chang, et al.
Publicado: (2019)

Prospective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEACentre
por: MacInnis, R J, et al.
Publicado: (2013)

BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface
por: Lee, A J, et al.
Publicado: (2014)

Incorporating Truncating Variants in PALB2, CHEK2 and ATM into the BOADICEA Breast Cancer Risk Model
por: Lee, Andrew J., et al.
Publicado: (2016)

BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors
por: Lee, Andrew, et al.
Publicado: (2019)

Distribution- and anchor-based methods to determine the minimally important difference on patient-reported outcome questionnaires in oncology: a structured review
por: Ousmen, Ahmad, et al.
Publicado: (2018)

The biological effects and clinical implications of BRCA mutations: where do we go from here?
por: Stoppa-Lyonnet, Dominique
Publicado: (2016)

Machine learning-based lifetime breast cancer risk reclassification compared with the BOADICEA model: impact on screening recommendations
por: Ming, Chang, et al.
Publicado: (2020)

Correction: BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors
por: Lee, Andrew, et al.
Publicado: (2019)

Prospective validation of the BOADICEA multifactorial breast cancer risk prediction model in a large prospective cohort study
por: Yang, Xin, et al.
Publicado: (2022)

Validation of the BOADICEA model for predicting the likelihood of carrying pathogenic variants in eight breast and ovarian cancer susceptibility genes
por: Møller, Nanna Bæk, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8aqf5nhvt5ehckbcnrslbkmca1